Monday, October 19, 2020 10:00:02 AM
New York Yankees and Duke Basketball
Recent ATHA News
- Form 8-K - Current report • Edgar (US Regulatory) • 09/17/2024 01:00:08 PM
- Athira Pharma to Focus on Advancement of ATH-1105 for the Treatment of Neurodegenerative Diseases • GlobeNewswire Inc. • 09/17/2024 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/05/2024 11:50:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/05/2024 11:49:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/05/2024 11:48:21 PM
- Nvidia Subpoenaed by DOJ, Athira Pharma Shares Plunge 71% After Study Fails, Zscaler Falls 15% Post-Earnings • IH Market News • 09/04/2024 09:50:25 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/03/2024 08:01:11 PM
- Athira Pharma Announces Topline Results from Phase 2/3 LIFT-AD Clinical Trial of Fosgonimeton for Mild-to-Moderate Alzheimer’s Disease • GlobeNewswire Inc. • 09/03/2024 08:01:00 PM
- Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend] • Edgar (US Regulatory) • 08/09/2024 08:05:13 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/01/2024 08:15:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2024 08:10:10 PM
- Athira Pharma Reports Second Quarter 2024 Financial Results and Pipeline and Business Updates • GlobeNewswire Inc. • 08/01/2024 08:05:00 PM
- Athira Pharma Presents Preclinical Data Demonstrating New Insights into the Mechanism by Which Fosgonimeton Protects Neurons from Alzheimer’s Disease-Related Pathology at the Alzheimer’s Association International Conference (AAIC) 2024 • GlobeNewswire Inc. • 07/31/2024 12:05:00 PM
- Athira to Host Webinar Highlighting Potential for Fosgonimeton to Protect and Preserve Neuronal Health in Mild-to-Moderate Alzheimer’s Disease Patients • GlobeNewswire Inc. • 06/12/2024 11:00:00 AM
- Athira Pharma Completes First Cohort in Phase 1 Clinical Trial of ATH-1105, an Oral, Small Molecule Drug Candidate for Amyotrophic Lateral Sclerosis (ALS) • GlobeNewswire Inc. • 06/11/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/29/2024 08:05:10 PM
- Athira Pharma to Participate in Upcoming June Conferences • GlobeNewswire Inc. • 05/29/2024 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/24/2024 11:03:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/24/2024 10:58:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/24/2024 10:56:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/17/2024 09:00:13 PM
- Athira Pharma Announces Proposed Settlement of Stockholder Derivative Action • GlobeNewswire Inc. • 05/17/2024 09:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2024 08:10:16 PM
- Athira Pharma Reports First Quarter 2024 Financial Results and Pipeline and Business Updates • GlobeNewswire Inc. • 05/15/2024 08:05:00 PM
- Athira Pharma to Participate in Upcoming May Conferences • GlobeNewswire Inc. • 05/02/2024 11:00:00 AM
FEATURED Nightfood Signs Letter of Intent to Acquire Los Angeles Cooking School, Integrating Automation and Robotics with World-Class Culinary Training • Oct 1, 2024 8:30 AM
FEATURED ZenaTech, Inc. (NASDAQ: ZENA) To Commence Trading Today • Oct 1, 2024 7:00 AM
Integrated Ventures, Inc Reports Total 2024 Revenues Of $5,863,935 vs $3,862,849 for 2023. • INTV • Oct 1, 2024 9:00 AM
Element79 Gold Corp secures loi for launching tailings reprocessing business in Arequipa, Peru • ELMGF • Oct 1, 2024 6:38 AM
BARRON'S COVE to Premier at the Hamptons International Film Festival • APHP • Sep 30, 2024 2:56 PM
Lingerie Fighting Championships Signs Broadcast Deal With Maybacks Global Entertainment • BOTY • Sep 26, 2024 9:00 AM